Engelman R M, Levitsky S, O'Donoghue M J, Auvil J
Department of Surgery, The Abraham Lincoln School of Medicine, The University of Illinois at the Medical Center, Chicago, USA.
Circulation. 1978 Sep;58(3 Pt 2):I107-13.
A standard experimental protocol was developed to explore the role of hypothermia and potassium cardioplegia in myocardial preservation during 120 minutes of ischemic arrest followed by 30 minutes of reperfusion. Seven different experimental groups of six animals each were evaluated using an in-vivo pig heart preparation. Hypothermic arrest without cardioplegia and cardioplegic arrest at normothermia were each compared to hypothermic cardioplegia. In addition, the use of an asanguineous hypothermic coronary perfusate without cardioplegia was compared to both multidose cardioplegia and single-dose cardioplegia followed by the same asanguineous perfusate. The parameters measured included: myocardial contractility and compliance, myocardial blood flow, endocardial/epicardial blood flow ratio, and electron microscopic studies. Myocardial preservation was inadequate with hypothermic arrest alone (without cardioplegia; and with cardioplegia at normothermia. In both experimental groups, myocardial contractility and compliance were so depressed that the) could not be accurately measured following ischemia and reperfusion while coronary blood flow remained significantly elevated. Preservation was improved but still inadequate following myocardial washout with a normokalemic or hypokalemic perfusate and following single dose cardioplegia plus myocardial washout. In the latter four groups, contractility ranged from 42 to 78% of control, and there was a decrease in compliance of 16 to 78%. Adequate preservation was found only after hypothermia and multidose potassium (35 mEq/L) cardioplegia. In this group, contractility was 129 +/- 13% of control and compliance increased by 21 +/- 24% compared to that of the control.
制定了一项标准实验方案,以探讨低温和钾停搏在缺血性停搏120分钟后再灌注30分钟期间心肌保护中的作用。使用猪心脏在体标本对7个不同的实验组进行评估,每组6只动物。将无停搏液的低温停搏和常温下的停搏液停搏分别与低温停搏液进行比较。此外,将无停搏液的无血低温冠状动脉灌注液的使用与多剂量停搏液和单剂量停搏液后再使用相同的无血灌注液进行比较。测量的参数包括:心肌收缩性和顺应性、心肌血流量、心内膜/心外膜血流比值以及电子显微镜研究。单独低温停搏(无停搏液;以及常温下使用停搏液)时心肌保护不充分。在这两个实验组中,心肌收缩性和顺应性均严重降低,以至于在缺血和再灌注后无法准确测量,而冠状动脉血流量仍显著升高。用正常钾或低钾灌注液进行心肌冲洗后以及单剂量停搏液加心肌冲洗后,心肌保护有所改善但仍不充分。在后四组中,收缩性为对照的42%至78%,顺应性下降了16%至78%。仅在低温和多剂量钾(35 mEq/L)停搏液后发现了充分的心肌保护。在该组中,收缩性为对照的129±13%,顺应性比对照增加了21±24%。